NCT07504445 2026-03-31
Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors
Peking University Shenzhen Hospital
Phase EARLY_PHASE1 Recruiting
Clinical Trials
15 trialsNCT07438093 2026-02-27
Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors
The First Affiliated Hospital of Xiamen University
Phase NA Not yet recruiting
NCT05605496 2026-02-10
IMMUNONET
Centre Leon Berard
Phase 2 Active not recruiting
NCT06556108 2026-01-20
ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors
Xinqiao Hospital of Chongqing
Phase 1/2 Completed
NCT07349160 2026-01-16
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT07285395 2025-12-16
AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Recruiting
NCT06840821 2025-12-02
Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors
Mainline Biosciences (Shanghai) Co., Ltd
Phase 1/2 Recruiting
NCT07207681 2025-10-06
Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
The First Hospital of Jilin University
Phase 1 Not yet recruiting
NCT03191682 2025-09-25
A First-in-Human Study of PRL3-ZUMAB
National University Hospital, Singapore
Phase 1 Active not recruiting
NCT07170787 2025-09-12
A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Not yet recruiting
NCT07101549 2025-08-03
Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase 1 Not yet recruiting
NCT06610227 2025-07-16
A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Active not recruiting
NCT06719362 2025-07-10
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Providence Health & Services
Phase 1 Recruiting
NCT07046650 2025-07-01
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
Fudan University
Phase 2 Recruiting
NCT06954558 2025-05-01
GUARDIAN
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Recruiting